Drreddys Laboratories | RDY - Interest Expense On Debt


Drreddys Laboratories reported INR1.06B in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
ANI Pharmaceuticals USD 4.41M 316K Dec/2025
Aurora Cannabis CAD 230K 1.88M Mar/2026
Bayer EUR 675M 87M Dec/2025
Canopy Growth CAD 12.31M 4.97M Mar/2026
Cipla INR 131.3M 9M Mar/2026
Corcept Therapeutics USD 814.88M 809.46M Mar/2026
Drreddys Laboratories INR 1.06B 113M Mar/2026
GlaxoSmithKline GBP 167M 21M Mar/2026
Hikma Pharmaceutical USD 67M 47M Dec/2025
Lonza CHF 84M 14M Jun/2025
Novartis USD 343M 39M Mar/2026
Pacira USD 3.7M 193K Mar/2026
Phibro Animal Health USD 11.91M 191K Dec/2025
Prestige Brands USD 10.67M 636K Dec/2025
Richter Gedeon HUF 7.5B 9.53B Sep/2024
Sun Pharmaceuticals INR 998.6M 250.6M Sep/2025
Supernus Pharmaceuticals USD 910K 278K Jun/2023
Teva Pharmaceutical Industries USD 216M 4M Mar/2026